Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals Performance
Day Range
- Low 45.65
- High 46.50
52 Week Range
- Low 22.00
- High 55.90
- Open Price0.00
- Previous Close46.55
- Volume2552
Start SIP in Aarey Drugs & Pharmaceuticals
Start SIPAarey Drugs & Pharmaceuticals Investment Rating
-
Master Rating:
-
Aarey Drugs & Pharms. has an operating revenue of Rs. 329.44 Cr. on a trailing 12-month basis. An annual revenue de-growth of -15% needs improvement, Pre-tax margin of 1% needs improvement, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 24% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 58 | 51 | 158 | 62 | 76 | 117 | 120 |
Operating Expenses Qtr Cr | 56 | 50 | 160 | 61 | 72 | 118 | 118 |
Operating Profit Qtr Cr | 2 | 1 | -2 | 2 | 4 | -1 | 2 |
Depreciation Qtr Cr | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Interest Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Tax Qtr Cr | 0 | 0 | 2 | 0 | 0 | 0 | 3 |
Net Profit Qtr Cr | 1 | 1 | 0 | 0 | 3 | 1 | -1 |
Aarey Drugs & Pharmaceuticals Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- ₹47.06
- 50 Day
- ₹46.15
- 100 Day
- ₹43.82
- 200 Day
- ₹40.63
- 20 Day
- ₹47.66
- 50 Day
- ₹46.14
- 100 Day
- ₹44.46
- 200 Day
- ₹36.80
Aarey Drugs & Pharmaceuticals Resistance and Support
Resistance | |
---|---|
First Resistance | 46.25 |
Second Resistance | 46.80 |
Third Resistance | 47.10 |
RSI | 44.91 |
MFI | 78.72 |
MACD Single Line | 0.65 |
MACD | 0.40 |
Support | |
---|---|
First Resistance | 45.40 |
Second Resistance | 45.10 |
Third Resistance | 44.55 |
Aarey Drugs & Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 3,399 | 339,900 | 100 |
Week | 6,566 | 656,600 | 100 |
1 Month | 36,715 | 3,671,471 | 100 |
6 Month | 113,035 | 7,678,475 | 67.93 |
Aarey Drugs & Pharmaceuticals Result Highlights
Aarey Drugs & Pharmaceuticals Synopsis
NSE-Medical-Diversified
Aarey Drugs & Ph is involved in the business activities of Activities of commission agents dealing in wholesale trade inwood, paper, skin, leather and fur, fuel, petroleum products, chemicals, perfumery and cosmetics, glass, minerals, ores and metals. Company’s Total Operating Revenue is Rs. 418.96 Cr. and Equity Capital is Rs. 25.38 Cr. for the Year ended 31/03/2023. Aarey Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/05/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1990PLC056538 and registration number is 056538.Market Cap | 116 |
Sales | 329 |
Shares in Float | 1.27 |
No of funds | 3 |
Yield | 0.44 |
Book Value | 0.99 |
U/D Vol ratio | 1.1 |
LTDebt / Equity | 4 |
Alpha | 0.11 |
Beta | 0.87 |
Aarey Drugs & Pharmaceuticals
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 50.04% | 50.04% | 50.04% | 50.03% |
Foreign Portfolio Investors | 3.94% | 3.92% | 3.92% | 3.92% |
Individual Investors | 40.61% | 42.24% | 42.24% | 42.41% |
Others | 5.41% | 3.8% | 3.8% | 3.64% |
Aarey Drugs & Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Mihir R Ghatalia | Chairman & Managing Director |
Mr. Nimit Rajesh Ghatalia | Executive Director |
Ms. Archana Pramod Wani | Woman Director |
Mr. Lalit Radhakrishna Tulsiani | Independent Director |
Mr. Anil Mandal | Independent Director |
Mr. Chetan K Mehta | Independent Director |
Aarey Drugs & Pharmaceuticals Forecast
Price Estimates
Aarey Drugs & Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-11 | Quarterly Results | |
2023-08-14 | Quarterly Results | |
2023-08-10 | Preferential issue & Issue of Warrants | |
2023-07-31 | Preferential issue of shares | |
2023-06-21 | Preferential issue of shares |
Aarey Drugs & Pharmaceuticals FAQs
What is Share Price of Aarey Drugs & Pharmaceuticals ?
Aarey Drugs & Pharmaceuticals share price is ₹46 As on 03 December, 2023 | 22:01
What is the Market Cap of Aarey Drugs & Pharmaceuticals ?
The Market Cap of Aarey Drugs & Pharmaceuticals is ₹118.2 Cr As on 03 December, 2023 | 22:01
What is the P/E ratio of Aarey Drugs & Pharmaceuticals ?
The P/E ratio of Aarey Drugs & Pharmaceuticals is 49.9 As on 03 December, 2023 | 22:01
What is the PB ratio of Aarey Drugs & Pharmaceuticals ?
The PB ratio of Aarey Drugs & Pharmaceuticals is 1 As on 03 December, 2023 | 22:01